Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Completed Phase 4 Trials for Diphtheria / Acellular Pertussis / Tetanus Prevention

Back to Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)

Indications	Status	Purpose	Phase
DBCOND0000394 (Diphtheria) DBCOND0031302 (Acellular Pertussis) DBCOND0000386 (Tetanus)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00282295	US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (DB10798) Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (DB10799) Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (DB10801) Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (DB10800)
NCT00610168	Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Pentetic acid (DB14007)
NCT01147900	Evaluation of Boostrix™10 Years After Previous Booster Vaccination	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)
NCT01294605	Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Pentetic acid (DB14007)
NCT01362322	Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)